Browse studies

Find your next paid study

1 recruiting study matching your filters

Epcoritamab in Combination With Dose Adjusted R-EPOCH for High Risk Burkitt Lymphoma (BL) (BEDROCK Study)

This phase II trial studies how well epcoritamab works in combination with the chemotherapy regimen dose adjusted etoposide, prednisone, Oncovin (vincristine),…

Adult Burkitt Lymphoma

Estimated

~$10 – $7,500

AIDS Malignancy ConsortiumNCT07662928